LV10426B - STABLE SALTS OF (+)-(1S,2R)-2-{£N-(2-hydroxylamino-2-oxoethyl)-N-methylamino|carbonyl}-cyclohexane-1-carbocyclic acid, process for their preparation and pharmaceutical compositions containing them - Google Patents
STABLE SALTS OF (+)-(1S,2R)-2-{£N-(2-hydroxylamino-2-oxoethyl)-N-methylamino|carbonyl}-cyclohexane-1-carbocyclic acid, process for their preparation and pharmaceutical compositions containing them Download PDFInfo
- Publication number
- LV10426B LV10426B LVP-92-358A LV920358A LV10426B LV 10426 B LV10426 B LV 10426B LV 920358 A LV920358 A LV 920358A LV 10426 B LV10426 B LV 10426B
- Authority
- LV
- Latvia
- Prior art keywords
- oxoethyl
- carbonyl
- cyclohexane
- methylamino
- hydroxylamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI913448A IT1252708B (it) | 1991-12-23 | 1991-12-23 | Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV10426A LV10426A (lv) | 1995-02-20 |
| LV10426B true LV10426B (en) | 1995-08-20 |
Family
ID=11361409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-92-358A LV10426B (en) | 1991-12-23 | 1992-12-23 | STABLE SALTS OF (+)-(1S,2R)-2-{£N-(2-hydroxylamino-2-oxoethyl)-N-methylamino|carbonyl}-cyclohexane-1-carbocyclic acid, process for their preparation and pharmaceutical compositions containing them |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0575572A1 (de) |
| JP (1) | JPH06506002A (de) |
| CN (1) | CN1079474A (de) |
| AU (1) | AU657591B2 (de) |
| BG (1) | BG98050A (de) |
| BR (1) | BR9205652A (de) |
| CA (1) | CA2104372A1 (de) |
| CZ (1) | CZ379692A3 (de) |
| EE (1) | EE9400006A (de) |
| FI (1) | FI933685A (de) |
| HR (1) | HRP921454A2 (de) |
| HU (1) | HUT69287A (de) |
| IT (1) | IT1252708B (de) |
| LV (1) | LV10426B (de) |
| MA (1) | MA22749A1 (de) |
| MX (1) | MX9207543A (de) |
| NZ (1) | NZ245547A (de) |
| PL (1) | PL169086B1 (de) |
| PT (1) | PT101156A (de) |
| RU (1) | RU2079489C1 (de) |
| SI (1) | SI9200409A (de) |
| SK (1) | SK379692A3 (de) |
| TN (1) | TNSN92117A1 (de) |
| WO (1) | WO1993013056A1 (de) |
| YU (1) | YU110892A (de) |
| ZA (1) | ZA9210004B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1264860B1 (it) * | 1993-06-21 | 1996-10-17 | Guidotti & C Spa Labor | Derivati di acidi cis- e trans-2(((2-(isdrossiammino)-2-ossoetil)- alchilammino)carbonil)cicloesancarbossilici |
| US5639746A (en) * | 1994-12-29 | 1997-06-17 | The Procter & Gamble Company | Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| FR2817241B1 (fr) | 2000-11-30 | 2003-03-07 | Cebal | Tube aluminium avec embout secable |
| US20100035991A1 (en) * | 2006-09-28 | 2010-02-11 | Mckeown Arlene | Amide base salts of saha and polymorphis thereof |
| AU2021263319B2 (en) * | 2020-04-27 | 2022-12-01 | Carter-Hoffmann, Llc | Door movement system for cabinet |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1224627B (it) * | 1988-04-12 | 1990-10-04 | Guidotti & C Spa Labor | Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono. |
-
1991
- 1991-12-23 IT ITMI913448A patent/IT1252708B/it active IP Right Grant
-
1992
- 1992-12-12 AU AU30871/92A patent/AU657591B2/en not_active Ceased
- 1992-12-12 JP JP5511398A patent/JPH06506002A/ja active Pending
- 1992-12-12 BR BR9205652A patent/BR9205652A/pt not_active Application Discontinuation
- 1992-12-12 WO PCT/EP1992/002903 patent/WO1993013056A1/en not_active Application Discontinuation
- 1992-12-12 EP EP92924726A patent/EP0575572A1/de not_active Withdrawn
- 1992-12-12 RU RU9293052414A patent/RU2079489C1/ru active
- 1992-12-12 HU HU9302389A patent/HUT69287A/hu unknown
- 1992-12-12 CA CA002104372A patent/CA2104372A1/en not_active Abandoned
- 1992-12-21 CZ CS923796A patent/CZ379692A3/cs unknown
- 1992-12-21 NZ NZ245547A patent/NZ245547A/en unknown
- 1992-12-21 SK SK3796-92A patent/SK379692A3/sk unknown
- 1992-12-22 MA MA23040A patent/MA22749A1/fr unknown
- 1992-12-22 SI SI9200409A patent/SI9200409A/sl unknown
- 1992-12-22 HR HR921454A patent/HRP921454A2/hr not_active Application Discontinuation
- 1992-12-23 LV LVP-92-358A patent/LV10426B/lv unknown
- 1992-12-23 CN CN92113839A patent/CN1079474A/zh active Pending
- 1992-12-23 PT PT101156A patent/PT101156A/pt not_active Application Discontinuation
- 1992-12-23 YU YU110892A patent/YU110892A/sh unknown
- 1992-12-23 ZA ZA9210004A patent/ZA9210004B/xx unknown
- 1992-12-23 PL PL92297118A patent/PL169086B1/pl unknown
- 1992-12-23 MX MX9207543A patent/MX9207543A/es unknown
- 1992-12-23 TN TNTNSN92117A patent/TNSN92117A1/fr unknown
-
1993
- 1993-08-18 BG BG98050A patent/BG98050A/bg unknown
- 1993-08-20 FI FI933685A patent/FI933685A/fi not_active Application Discontinuation
-
1994
- 1994-05-23 EE EE9400006A patent/EE9400006A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06506002A (ja) | 1994-07-07 |
| ZA9210004B (en) | 1993-12-13 |
| AU3087192A (en) | 1993-07-28 |
| CN1079474A (zh) | 1993-12-15 |
| ITMI913448A1 (it) | 1993-06-23 |
| YU110892A (sh) | 1996-01-08 |
| HUT69287A (en) | 1995-09-28 |
| BR9205652A (pt) | 1994-05-03 |
| CA2104372A1 (en) | 1993-06-24 |
| MA22749A1 (fr) | 1993-07-01 |
| RU2079489C1 (ru) | 1997-05-20 |
| SI9200409A (en) | 1993-09-30 |
| HU9302389D0 (en) | 1993-11-29 |
| TNSN92117A1 (fr) | 1993-06-08 |
| BG98050A (bg) | 1994-04-29 |
| MX9207543A (es) | 1993-08-01 |
| IT1252708B (it) | 1995-06-26 |
| PT101156A (pt) | 1994-06-30 |
| WO1993013056A1 (en) | 1993-07-08 |
| EE9400006A (et) | 1995-12-15 |
| ITMI913448A0 (it) | 1991-12-23 |
| LV10426A (lv) | 1995-02-20 |
| HRP921454A2 (en) | 1995-02-28 |
| AU657591B2 (en) | 1995-03-16 |
| FI933685A0 (fi) | 1993-08-20 |
| CZ379692A3 (en) | 1993-09-15 |
| PL297118A1 (en) | 1993-09-06 |
| SK379692A3 (en) | 1995-04-12 |
| FI933685A (fi) | 1993-08-20 |
| NZ245547A (en) | 1995-12-21 |
| EP0575572A1 (de) | 1993-12-29 |
| PL169086B1 (pl) | 1996-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR890000007B1 (ko) | 시스, 엔도-2-아자비사이클로-[3.3.0]-옥탄-3-카복실산 유도체의 제조방법 | |
| KR910000234B1 (ko) | 시스, 엔도-2-아자비사이클로[5.3.0]데칸-3-카복실산 유도체의 제조방법 | |
| US4668796A (en) | Racemates of optically active bicyclic imino-alpha-carboxylic esters | |
| IE60128B1 (en) | Hydroxylamine derivatives,their preparation and use as medicaments | |
| JPS58177968A (ja) | アザスピロ−カルボン酸誘導体 | |
| NZ206236A (en) | 3-(4-(1-carboxyalk-3-yl)-alpha-aminoalkanoyl)-3-azatricyclo-(5.2.1.0 2-6 ) decan-4-ylcarboxylic acids | |
| IE56544B1 (en) | New spirocyclic aminoacid derivatives,processes for their preparation,agents containing them and their use and new spirocyclic aminoacids as intermediates and processes for their preparation | |
| LV10426B (en) | STABLE SALTS OF (+)-(1S,2R)-2-{£N-(2-hydroxylamino-2-oxoethyl)-N-methylamino|carbonyl}-cyclohexane-1-carbocyclic acid, process for their preparation and pharmaceutical compositions containing them | |
| NO851495L (no) | Syntese av cyklopropanaminosyrer og -peptider | |
| JPH0531544B2 (de) | ||
| IE56654B1 (en) | A process for the resolution of racemates of optically active bicyclic imino-alpha-carboxylic esters,and the use of the compounds thus obtainable for the synthesis of carboxyalkyldipeptides | |
| HRP960303A2 (en) | Improvement of physiological tolerance of pharmaceutical active beta-amino acids | |
| US4920144A (en) | Derivatives of bicyclic amino acids, agents containing them and their use as hypotensives | |
| US4370494A (en) | Converting enzyme inhibitors | |
| DD206553A5 (de) | Verfahren zur herstellung von tripeptiden | |
| US4113877A (en) | Substituted 2-aminomethylphenyl sulfamates | |
| US5175306A (en) | Process for the resolution of racemates of optically active bicyclic imino-α-carboxylic esters | |
| US5948939A (en) | Selective amidination of diamines | |
| IE53315B1 (en) | Substituted dipeptides,processes for their preparation and pharmaceutical compositions containing them and their use in the inhibition of enkephalinase | |
| IKEDA et al. | Total syntheses of bellenamine and its isomers | |
| EP0214570A2 (de) | Neue N-alkylierte Tripeptide, Verfahren zu ihrer Herstellung, sie enthaltende Medikamente und deren Verwendung | |
| US4073807A (en) | Propionamide antitumor agents | |
| Bland | THE SYNTHESIS OF BETA-FUNCTIONALIZED CYCLOPROPYL AMINO ACIDS AND MODIFIED PEPTIDES: PART I. 5-AMINO-3-PENTENOIC ACID. PART II. CYCLOPROPYL BETA-HETERO-ALANINE. PART III. CYCLOPROPYL METHIONINE (EFE, ACC, ENKEPHALIN) |